Abstract
Multiple sclerosis (MS) is a chronic, neurological, immune-mediated disease that can worsen in the postpartum period. There is no consensus on the use of immunoglobulin for prevention of disease relapses after delivery. We have shown that the controversial beneficial effect of immunoglobulin given immediately after birth could not be observed in patients with MS.
MeSH terms
-
Adult
-
Case-Control Studies
-
Female
-
Humans
-
Immunoglobulins, Intravenous / pharmacology
-
Immunoglobulins, Intravenous / therapeutic use*
-
Mothers*
-
Multiple Sclerosis / complications
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / physiopathology
-
Multiple Sclerosis, Relapsing-Remitting / prevention & control*
-
Postpartum Period / drug effects*
-
Pregnancy
-
Pregnancy Complications / drug therapy
-
Pregnancy Complications / immunology
-
Pregnancy Outcome
-
Puerperal Disorders / prevention & control
-
Recurrence
-
Retrospective Studies
-
Risk Assessment
-
Risk Factors
-
Treatment Outcome
Substances
-
Immunoglobulins, Intravenous